APA (7th ed.) Citation

G, F., C, B. X., D, V. V., J, M., S, S., AR, K., . . . DS, H. (2026). A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumors. NPJ precision oncology, 10(1), . https://doi.org/10.1038/s41698-026-01340-1

Chicago Style (17th ed.) Citation

G, Falchook, et al. "A First-in-human Phase 1 Study of the SHP2 Inhibitor BBP-398 in Patients with Advanced Solid Tumors." NPJ Precision Oncology 10, no. 1 (2026). https://doi.org/10.1038/s41698-026-01340-1.

MLA (9th ed.) Citation

G, Falchook, et al. "A First-in-human Phase 1 Study of the SHP2 Inhibitor BBP-398 in Patients with Advanced Solid Tumors." NPJ Precision Oncology, vol. 10, no. 1, 2026, https://doi.org/10.1038/s41698-026-01340-1.